Test Code LAB320 INR
Additional Codes
PROTIME
Test Performed By
Cayuga Medical Center, Main Laboratory
Container Name
Light-blue top (citrate)
Day(s) and Time(s) Test Performed
Monday through Sunday; Continuously
List Price
$46.00
CPT Codes
85610
Temperature
Ambient or refrigerated
Clinical and Interpretive
The prothrombin time (PT) represents the time elapsed between 1) addition of a standardized mixture of tissue thromboplastin and calcium to citrate anticoagulated plasma and 2) detection of clot formation, representing fibrin polymerization resulting from the generation of thrombin, which proteolytically transforms fibrinogen to fibrin. A prolonged PT indicates deficiency of 1 or more coagulation factors (I, II, V, VII, or X) or the presence of a coagulation inhibitor. The PT is the most common test used for monitoring oral anticoagulant therapy (warfarin or Coumadin, and congeners). Oral anticoagulants reduce the activities of the 4 vitamin K-dependent procoagulant factors (factors II, VII, IX, and X), and the PT is sensitive to 3 of them. The PT requires standardization because there are numerous thromboplastins and coagulation testing instruments, and they all vary in their responsiveness to the concentrations or activities of coagulation proteins. The international normalized ratio (INR) is a method of standardizing PT reporting for monitoring the intensity of oral anticoagulant therapy. The INR is the ratio of the patient’s PT to the laboratory’s mean normal (reference) PT. The international sensitivity index (ISI) is an experimentally derived measurement, usually provided by the thromboplastin manufacturer, reflecting thromboplastin (and PT) sensitivity to coagulation deficiencies. More sensitive thromboplastins have a low ISI (1.0-1.2), whereas less sensitive thromboplastins have a higher ISI (eg, 2.0-3.0).
Calculation of the INR is as follows:
INR = (Patient’s PT/mean PT of reference range) ISI where:
-INR=international normalized ratio
-ISI=international sensitivity index
The INR is used only for patients on stable oral anticoagulant therapy. It makes no significant contribution to the diagnosis or treatment of patients whose PT is prolonged for other reasons.
Recommended INR therapeutic ranges for orally administered drugs are as follows:
-Anticoagulation intensity: INR
-Standard intensity: 2.0 to 3.0
-Higher intensity: 3.0 to 4.5
Specimen Type
Whole Blood
Specimen Volume
4 mL
Minimum Specimen Volume
4 mL
Specimen Stability
Stability: 24 hours